A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NextPoint Therapeutics, Inc.
NextPoint Therapeutics, Inc.
National Cancer Institute (NCI)
BioEclipse Therapeutics
Celgene
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
Children's Oncology Group
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)